Key figures on U.S. public biotech companies 2012-2016
This statistic contains key figures on U.S. public biotech companies from 2012 to 2016. In 2016, U.S. public biotech companies generated some 112 billion U.S. dollars of revenue in total. In the same year, research and development spending came to nearly 39 billion dollars.
